PharmaPendium Training and Support
CONTENT, COVERAGE and INDEXING
How often are MedDRA updates made?
Every 2 months.
How do you integrate RTECS toxicity classification with MedDRA classification?
RTECS terms have been mapped to the proper term and level of the MedDRA hierarchy, and then these RTECS terms are added to the Thesaurus as synonyms to these MedDRA terms. Where there are RTCS terms that cannot be mapped, specific entries were added to the hierarchy.
How is drug class defined?
PharmaPendium uses Mosby's Drug Consult class definitions. Mosby's uses FDA classifications.
Does Pharmapendium have target information for every drug?
Pharmapendium does not have target information on every drug yet, but claims to have every target for every drug. This is an ongoing process and approximately 2000 new drug/target relationships have already been added.
How often is Pharmapendium updated and what does this include?
Content Updates occur every 2 months and includes any source updates that fall into that timing:
- FDA docs: every update
- Meyler's: 1 update/year
- RTECS: Quarterly
- Metabolite: Quarterly
- Mosby's: none – to be updated with Daily Med Lables starting 10/2007
- AERS: Quarterly, but usually provided ~6 months late by FDA
SUBSCRIBING AND TRIALS
For checking if MDL Draw has been installed, you should make sure that c:\Program Files\Java\jre1.5.0_11\lib\ext\" folder contains:
There are no other ways to check if MDL Draw has been installed on your PC.
There is a SCR cct00099020 related to the installation of MDL Draw.
User should click on "Chemistry Search" again. And chemistry search box will appear.
Why do you need a MedDRA license?
All customers are required to have a license with MedDRA, a thesaurus provided by the ICH (MSSO). Most large and medium biopharma account will have this license, however very small biotechs and academics might need to set this up.
On the PharmaPendium interface the following message is displayed:
'The Toxicity / Adverse Effects tree displayed is a combination of terms from RTECS (r), MedDRA (r) and other terms extracted from various content sources. For that reason, this tree cannot be used for coding of human adverse events reports for submission to regulatory agencies. MedDRA(r) should be licensed from the International Conference on Harmonization for that purpose.'
Is this a secure site? Will my search be captured?
The secure network protocol, HTTPS, is implemented.
Do I need to install any software in order to use PharmaPendium?
PharmaPendium is web-based product. Only when you want to do structure search by importing structure files or drawing your own structure, you need to install MDL Draw onto your computer. Its downloading link is provided with PharmaPendium.
If you only want to search structures from a drug information page, you don't need to have MDL Draw. You will also need to have Adobe Acrobat Reader 7.0 for optimal use.
Which browsers are supported for PharmaPendium?
- Safari version 2.0.3
- IE version 6.0 SP1
System Requirements for PharmaPendium access
- Mozilla FireFox 3 or higher
- Safari 4 or higher
- Internet Explorer 6 SP3 or higher
- Windows 2000 Server SP3 or higher
- Windows 2000 Server Kanji SP3 or higher
- Windows XP SP2
- Windows XP Kanji SP2
- Windows 7
- Macintosh OS X 'Tiger' (version 10.4)
PharmaPendium PDF Viewer:
Because the latest version of Adobe, Adobe X, no longer supports highlighting from external servers, PharmaPendium now has its own in-house PDF Viewer. Improvements include:
- Significantly improved performance when downloading PDFs. Users should see a performance improvement from 10X to 100X.
- No software download is needed. The PDF Viewer is embedded within the PharmaPendium platform.
- PharmaPendium users can still view and save documents in Adobe if they wish.
Display: Optimized for 1024 x 768 screen resolution.
Guides and Manuals
360 Park Avenue South
New York, NY 10010-1710 USA
Tel: +1 888 615 4500
(+1 212 462 1978, if calling from outside the USA and Canada)
Fax: +1 212 462 1974
|Europe, Middle East and Africa |
60486 Frankfurt/Main, Germany
Tel: +49-69-5050 4268
Fax: +49-69-5050 4213
Tokyo 106-0044 Japan
Tel: +81 3 5561 5035
Fax: +81 3 5561 5047